387 filings
ARS
2023 FY
TVTX
Travere Therapeutics Inc
27 Mar 24
Annual report to shareholders
4:35pm
DEFA14A
TVTX
Travere Therapeutics Inc
27 Mar 24
Additional proxy soliciting materials
4:33pm
DEF 14A
TVTX
Travere Therapeutics Inc
Definitive proxy
27 Mar 24
4:31pm
8-K
TVTX
Travere Therapeutics Inc
23 Feb 24
Other Events
4:05pm
10-K
2023 FY
TVTX
Travere Therapeutics Inc
Annual report
20 Feb 24
8:10am
8-K
08r64pi
15 Feb 24
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
8-K
0ovuh
8 Jan 24
Travere Therapeutics Provides Corporate Update and 2024 Outlook
7:07am
8-K
zvrjf
4 Dec 23
Cost Associated with Exit or Disposal Activities
4:10pm
8-K
irsa18dvl7 dbl9x
7 Nov 23
Travere Therapeutics Reports Third Quarter 2023 Financial Results
4:04pm
8-K
4o7tn59v6xqr
21 Sep 23
Other Events
7:35am
8-K/A
8zl nwvih7qjc9v
7 Sep 23
Financial Statements and Exhibits
5:00pm
8-K
wgtzn
5 Sep 23
Completion of Acquisition or Disposition of Assets
8:35am
S-8
bg7uhk6
3 Aug 23
Registration of securities for employees
5:11pm
8-K
kw62rfxfundue8
3 Aug 23
Travere Therapeutics Reports Second Quarter 2023 Financial Results
4:06pm
8-K
p6dvi
17 Jul 23
Entry into a Material Definitive Agreement
8:07am
8-K
mql6jn zedlxawbz6d
31 May 23
Other Events
4:57pm
8-K
qawmurh
22 May 23
Departure of Directors or Certain Officers
4:30pm